BackBright Health Group Overview

Bright Health Group EBIT

Track Bright Health Group's EBIT ($700M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$16.64M
75.33% YoY

As of Jun 30, 2025

Annual EBIT (TTM)

$699.26M
286.35% YoY

Trailing 12 months ending Jun 30, 2025

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Bright Health Group (BHG) FAQ

Bright Health Group posts a EBIT of $700M as of June 2025. That compares with $-380M in the prior-year period — up 286.3% year over year. That is below the Finance sector average of $350B. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Bright Health Group's EBIT was $-380M. The latest reading is $700M — a 286.3% year-over-year increase (period ending June 2025). Use the history and growth charts on this page for a longer lookback.

For Finance stocks, a EBIT near $350B is typical. Bright Health Group's $700M is lower that level. That is roughly 99.8% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

EBIT is one piece of Bright Health Group's financial statement story. At $700M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for BHG's EBIT usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $350B), and (3) consistency with growth and profitability. This page covers the first two; Bright Health Group's other metric pages and overview cover the third.